女性用健康診断薬市場世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測

Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

女性の健康診断の世界市場規模は、2022年に236億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.51%の成長率（CAGR）を示し、2028年までに373億米ドルに達すると予測しています。女性の... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
IMARC Services Private Limited. アイマークサービス	2023年3月18日	US$2,499 シングルユーザライセンスライセンス・価格情報注文方法はこちら	143	英語

サマリー

女性の健康診断の世界市場規模は、2022年に236億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.51%の成長率（CAGR）を示し、2028年までに373億米ドルに達すると予測しています。

女性の健康診断では、女性患者のさまざまな生物学的および心理社会的な状態を診断することができます。性的な問題や膣の問題、妊娠の合併症に対処し、骨粗しょう症や更年期障害、乳がんや子宮頸がんなどの脅威となる病気を管理することができます。生検、超音波検査、化学療法、磁気共鳴画像法（MRI）など、一連の高度な実験室検査、ツール、処置に依存しています。現在、いくつかの医療診断センターが、女性に影響を与える希少な病気や症状の診断と管理を強化するために、広範な臨床検査ソリューションを提供しています。

女性の健康診断の市場動向：
女性の全般的な幸福に影響を与える健康問題の有病率の上昇は、市場にプラスの影響を与える主要な要因の1つである。さらに、健康意識の高まりと早期診断の利点に関する意識の高まりが、世界中でポイントオブケア（POC）型女性用健康診断の需要を喚起しています。また、ストレスの多いライフスタイルやアルコール・薬物摂取の増加による不妊症の増加も、妊娠合併症に対処し、より健康な生活を送るための女性健康診断の必要性を高めています。さらに、更年期は心血管疾患や尿失禁など特定の疾患の発症リスクを高めるため、50歳以上の女性人口が大幅に増加し、市場の成長に寄与しています。これに加えて、いくつかの研究により、女性はホルモンの変化により、うつ病や不安症などの精神疾患を経験しやすいという結論が得られています。このことは、女性のメンタルヘルスを改善するために多くの国の保健機関が行っているいくつかの取り組みと相まって、全世界で市場の成長を促進しています。

主要な市場セグメンテーション
IMARC Groupは、2023年から2028年までの世界、地域、国レベルでの予測とともに、世界の女性用健康診断市場レポートの各サブセグメントにおける主要動向の分析を提供します。当レポートでは、市場をタイプ、アプリケーション、エンドユーザーに基づいて分類しています。

タイプ別構成比：

診断用機器
生検装置
イメージング・モニタリングデバイス
アクセサリー・消耗品
診断テスト
乳がん検査
PAPスメアとHPV検査
妊娠検査薬・排卵検査薬
その他

アプリケーション別のブレークアップ：

乳がん
感染症検査
骨粗鬆症検査
妊娠・不妊検査
性感染症検査
その他

エンドユーザー別構成比：

病院・診断センター
ホームケア

地域別構成比：

北アメリカ
ユーエスエー
カナダ
アジア太平洋
中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中近東・アフリカ

競争環境：
業界の競争環境は、Abbott Laboratories、Becton Dickinson and Company、bioMérieux SA、Cardinal Health Inc、Cook Group Incorporated、F. Hoffmann-La Roche AG、General Electric Company、Hologic Inc、Koninklijke Philips N.V., Perkinelmer Inc, Quest Diagnostics Inc、Siemens AG、Thermo Fisher Scientific Incの主要企業のプロファイルと共に調査されています。

本レポートで回答した主な質問

1.2022年の女性用健康診断薬の世界市場規模は？
2.2023-2028年の女性用健康診断の世界市場の予想成長率は？
3.世界の女性用健康診断薬市場を牽引する主要因は何か？
4.COVID-19が世界のウーマンヘルス診断薬市場に与えた影響とは？
5.女性用健康診断薬の世界市場のタイプ別内訳はどうなっているのか？
6.女性用健康診断薬の世界市場の用途別内訳は？
7.女性用健康診断薬の世界市場のエンドユーザー別の内訳は？
8.世界の女性用健康診断薬市場の主要地域は？
9.世界の女性用健康診断薬市場の主要プレイヤー/企業は？

ページTOPに戻る

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Women's Health Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Diagnostic Devices
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Biopsy Device
6.1.2.2 Imaging and Monitoring Devices
6.1.2.3 Accessories and Consumables
6.1.3 Market Forecast
6.2 Diagnostic Tests
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Breast Cancer Testing
6.2.2.2 PAP Smear and HPV Test
6.2.2.3 Pregnancy Testing and Ovulation Testing
6.2.2.4 Others
6.2.3 Market Forecast
7 Market Breakup by Application
7.1 Breast Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Infectious Disease Testing
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Osteoporosis Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pregnancy and Fertility Testing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Sexually Transmitted Disease Testing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospital and Diagnostics Centers
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Home Care
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 bioMérieux SA
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cook Group Incorporated
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 General Electric Company
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Hologic Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Koninklijke Philips N.V.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Perkinelmer Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Quest Diagnostics Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Siemens AG
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2022
Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2022
Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2022
Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2022
Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
Table 7: Global: Women's Health Diagnostics Market: Key Players

ページTOPに戻る

Table of Contents

Summary

The global women's health diagnostics market size reached US$ 23.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.3 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:
The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women’s health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women’s health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostic Devices
Biopsy Device
Imaging and Monitoring Devices
Accessories and Consumables
Diagnostic Tests
Breast Cancer Testing
PAP Smear and HPV Test
Pregnancy Testing and Ovulation Testing
Others

Breakup by Application:

Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others

Breakup by End User:

Hospital and Diagnostics Centers
Home Care

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What was the size of the global women’s health diagnostics market in 2022?
2. What is the expected growth rate of the global women’s health diagnostics market during 2023-2028?
3. What are the key factors driving the global women’s health diagnostics market?
4. What has been the impact of COVID-19 on the global women’s health diagnostics market?
5. What is the breakup of the global women’s health diagnostics market based on the type?
6. What is the breakup of the global women’s health diagnostics market based on the application?
7. What is the breakup of the global women’s health diagnostics market based on the end user?
8. What are the key regions in the global women’s health diagnostics market?
9. Who are the key players/companies in the global women’s health diagnostics market?

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（womens health）の最新刊レポート

よくあるご質問

IMARC Services Private Limited.社はどのような調査会社ですか?

インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

女性用健康診断薬市場世界の産業動向、シェア、サイズ、成長、機会、2023-2028年予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（womens health）の最新刊レポート

よくあるご質問

IMARC Services Private Limited.社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?